Working Paper of Public Health Volume 2012 - Azienda Ospedaliera ...
Working Paper of Public Health Volume 2012 - Azienda Ospedaliera ... Working Paper of Public Health Volume 2012 - Azienda Ospedaliera ...
Azienda Ospedaliera Nazionale“SS. Antonio e Biagio e Cesare Arrigo”Working Paper of Public Healthnr. 3/2012As it has been stressed, in this paper and others, the two kinds of legislation on cadavericorgan donation are imperfect, because there are always people whose true wills are notexecuted. In this way, policy makers must weigh the pros and cons of each piece oflegislation. The results reported in this paper could be used to clarify the benefits ofadopting presumed consent, which has a positive effect of 21-26% on cadaveric organdonation related to informed consent countries. In addition, the methodology applied inthis paper was able to provide evidence against a common belief in related literature thatpresumed consent has a positive effect only because of the outstanding Spanish donationrate. The left tail of distribution (countries with lower organ donation rate) has shown apositive impact on the response variable, which contradicts this common belief.Organ shortages can be worse since both celebro-vascular disease and traffic accidentrates have decreased over the years (-5.2% and -8.6%, respectively, from 1998 to 2002),because of specific public health policies in these areas. Based on this, the trend for thecontribution from these variables on organ donation can be lower over time. Therefore,health policy makers must be aware of that problem. The presumed consent law could bean alternative, not to solve the problem completely, but at least to reduce the gap betweendemand and supply of organ donation.There are other ways that the policy maker can improve the organ supply: increasinghealth expenditure and intensifying the dissemination of information about organdonation. A strong relationship was found between health expenditure and donation rates,especially in countries that are situated in the lower quantiles of the conditionaldistribution. This seems to be the most effective way of increasing organ donation forcountries that do not want to change the law to presumed consent or even for those thatalready have one, because the health policy maker has control of health expenditure,unlike other factors such as religious belief and the legal system (which also have apositive effect on the organ donation rate).Although educational campaigning has not been explicitly tested in this paper, it seems toplay an important role in organ donation, since a representative part of the population haslittle knowledge about legislation on organ donation. As our proxy for information(access to the Internet) has shown, there is a positive impact between it and the response17
Azienda Ospedaliera Nazionale“SS. Antonio e Biagio e Cesare Arrigo”Working Paper of Public Healthnr. 3/2012variable. Based on this, more information must be made available on different media.Educational campaigns also can avoid some problems as verified in the Brazilianexperience with presumed consent. Some authors have pointed out that presumed consentwas unsuccessful in Brazil because there was not a huge discussion about the law andrelated issues with transplantation, such as the strict proceedings to diagnose brain deathand the coordination of the waiting list.Finally, if health policy makers follow these recommendations a significant increase inorgan donation should be achieved and more transplants could be carried out, generatingbetter quality of life for patients, particularly in cases when such transplants are the onlyway to keep them alive. In this way, efficiency and equity -- the main goals for publichealth policies -- could be achievedReferencesABADIE, Alberto e GAY, Sebastien (2006). The Impact of Presumed ConsentLegislation on Cadaveric Organ Donation: a Cross-Country Study. Journal of HealthEconomics, vol. 25: 599-620ABREVAYA, Jason and DAHL, Christian (2005). The effect of smoking and prenatalcare on birth outcomes: evidence from quantile estimation on panel data.http://www.ssc.wisc.edu/~bhansen/workshop/abrevaya.pdf.ANBARCI, Nejat & CAGLAYAN, Mustafa (2005). Cadaveric vs. live-donor kidneytransplants: the interactions of institutions and inequalities. Working Paper FloridaInternational University (department of economics), number 05-17.http://www.fiu.edu/orgs/economics/wp2005/05-17.pdf.ANZOD. 2006. The Australia and New Zealand Organ Donation Registry. 2002 AnnualReport. http://www.anzdata.org.au/ANZOD/ANZODReport/anzodreport.htmBAGHERI, A. (2005). Organ Transplantation law in Asia Countries: A ComparativeStudy, Transplantation Proceeding, vol. 37:159-162.BALTAGI, Badi H. (2001). Econometric analysis of panel data. Second edition.18
- Page 2 and 3: La serie di Working Paper of Public
- Page 4 and 5: Azienda Ospedaliera Nazionale“SS.
- Page 6 and 7: Azienda Ospedaliera Nazionale“SS.
- Page 8 and 9: Azienda Ospedaliera Nazionale“SS.
- Page 10 and 11: Azienda Ospedaliera Nazionale“SS.
- Page 12 and 13: Azienda Ospedaliera Nazionale“SS.
- Page 14 and 15: Azienda Ospedaliera Nazionale“SS.
- Page 16 and 17: Azienda Ospedaliera Nazionale“SS.
- Page 18 and 19: Azienda Ospedaliera Nazionale“SS.
- Page 20 and 21: Azienda Ospedaliera Nazionale“SS.
- Page 22 and 23: Azienda Ospedaliera Nazionale“SS.
- Page 24 and 25: Azienda Ospedaliera NazionaleSS. An
- Page 26 and 27: Azienda Ospedaliera NazionaleSS. An
- Page 28 and 29: Azienda Ospedaliera NazionaleSS. An
- Page 30 and 31: Azienda Ospedaliera Nazionale“SS.
- Page 32 and 33: Azienda Ospedaliera Nazionale“SS.
- Page 34 and 35: Azienda Ospedaliera Nazionale“SS.
- Page 36 and 37: Azienda Ospedaliera Nazionale“SS.
- Page 38 and 39: Azienda Ospedaliera Nazionale“SS.
- Page 40 and 41: Azienda Ospedaliera Nazionale“SS.
- Page 42 and 43: Azienda Ospedaliera Nazionale“SS.
- Page 44 and 45: Azienda Ospedaliera Nazionale“SS.
- Page 48 and 49: Azienda Ospedaliera Nazionale“SS.
- Page 50 and 51: Azienda Ospedaliera Nazionale“SS.
- Page 52 and 53: Azienda Ospedaliera Nazionale“SS.
- Page 54 and 55: Azienda Ospedaliera Nazionale“SS.
- Page 56 and 57: Azienda Ospedaliera Nazionale“SS.
- Page 58 and 59: Azienda Ospedaliera Nazionale“SS.
- Page 60 and 61: Azienda Ospedaliera Nazionale“SS.
- Page 62 and 63: Azienda Ospedaliera Nazionale“SS.
- Page 64 and 65: Azienda Ospedaliera Nazionale“SS.
- Page 66 and 67: Azienda Ospedaliera Nazionale“SS.
- Page 68 and 69: Azienda Ospedaliera Nazionale“SS.
- Page 70 and 71: Azienda Ospedaliera Nazionale“SS.
- Page 72 and 73: Azienda Ospedaliera Nazionale“SS.
- Page 74 and 75: Azienda Ospedaliera Nazionale“SS.
- Page 76 and 77: Azienda Ospedaliera Nazionale“SS.
- Page 78 and 79: Azienda Ospedaliera Nazionale“SS.
- Page 80 and 81: Azienda Ospedaliera Nazionale“SS.
- Page 82 and 83: Azienda Ospedaliera Nazionale“SS.
- Page 84 and 85: Azienda Ospedaliera Nazionale“SS.
- Page 86 and 87: Azienda Ospedaliera Nazionale“SS.
- Page 88 and 89: Azienda Ospedaliera Nazionale“SS.
- Page 90 and 91: Azienda Ospedaliera Nazionale“SS.
- Page 92 and 93: Azienda Ospedaliera Nazionale“SS.
- Page 94 and 95: Azienda Ospedaliera Nazionale“SS.
<strong>Azienda</strong> <strong>Ospedaliera</strong> Nazionale“SS. Antonio e Biagio e Cesare Arrigo”<strong>Working</strong> <strong>Paper</strong> <strong>of</strong> <strong>Public</strong> <strong>Health</strong>nr. 3/<strong>2012</strong>As it has been stressed, in this paper and others, the two kinds <strong>of</strong> legislation on cadavericorgan donation are imperfect, because there are always people whose true wills are notexecuted. In this way, policy makers must weigh the pros and cons <strong>of</strong> each piece <strong>of</strong>legislation. The results reported in this paper could be used to clarify the benefits <strong>of</strong>adopting presumed consent, which has a positive effect <strong>of</strong> 21-26% on cadaveric organdonation related to informed consent countries. In addition, the methodology applied inthis paper was able to provide evidence against a common belief in related literature thatpresumed consent has a positive effect only because <strong>of</strong> the outstanding Spanish donationrate. The left tail <strong>of</strong> distribution (countries with lower organ donation rate) has shown apositive impact on the response variable, which contradicts this common belief.Organ shortages can be worse since both celebro-vascular disease and traffic accidentrates have decreased over the years (-5.2% and -8.6%, respectively, from 1998 to 2002),because <strong>of</strong> specific public health policies in these areas. Based on this, the trend for thecontribution from these variables on organ donation can be lower over time. Therefore,health policy makers must be aware <strong>of</strong> that problem. The presumed consent law could bean alternative, not to solve the problem completely, but at least to reduce the gap betweendemand and supply <strong>of</strong> organ donation.There are other ways that the policy maker can improve the organ supply: increasinghealth expenditure and intensifying the dissemination <strong>of</strong> information about organdonation. A strong relationship was found between health expenditure and donation rates,especially in countries that are situated in the lower quantiles <strong>of</strong> the conditionaldistribution. This seems to be the most effective way <strong>of</strong> increasing organ donation forcountries that do not want to change the law to presumed consent or even for those thatalready have one, because the health policy maker has control <strong>of</strong> health expenditure,unlike other factors such as religious belief and the legal system (which also have apositive effect on the organ donation rate).Although educational campaigning has not been explicitly tested in this paper, it seems toplay an important role in organ donation, since a representative part <strong>of</strong> the population haslittle knowledge about legislation on organ donation. As our proxy for information(access to the Internet) has shown, there is a positive impact between it and the response17